牛牛AI助理已提取核心訊息
Erqi Wang, a significant shareholder in Jin Medical International Ltd., has filed a Schedule 13G with the United States Securities and Exchange Commission (SEC) on December 31, 2023, indicating a substantial ownership stake in the company. According to the filing, Wang holds a total of 107,126,140 ordinary shares, representing 68.43% of the company's class of securities after adjustments for a 20-for-1 forward stock split effective February 8, 2024. This ownership includes direct holdings through Jolly Harmony Enterprises Limited and Er Pu International Limited, both entities organized under the laws of the British Virgin Islands. Jolly Harmony Enterprises Limited, wholly owned by Wang, holds 95,381,140 shares, amounting to 60.93% of the class, while Er Pu International Limited, in which Wang has a 67% ownership, holds 11,745,000 shares, representing 7.50% of the class. The filing, completed on February 14, 2024, asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Jin Medical International Ltd.
Erqi Wang, a significant shareholder in Jin Medical International Ltd., has filed a Schedule 13G with the United States Securities and Exchange Commission (SEC) on December 31, 2023, indicating a substantial ownership stake in the company. According to the filing, Wang holds a total of 107,126,140 ordinary shares, representing 68.43% of the company's class of securities after adjustments for a 20-for-1 forward stock split effective February 8, 2024. This ownership includes direct holdings through Jolly Harmony Enterprises Limited and Er Pu International Limited, both entities organized under the laws of the British Virgin Islands. Jolly Harmony Enterprises Limited, wholly owned by Wang, holds 95,381,140 shares, amounting to 60.93% of the class, while Er Pu International Limited, in which Wang has a 67% ownership, holds 11,745,000 shares, representing 7.50% of the class. The filing, completed on February 14, 2024, asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Jin Medical International Ltd.
金醫療國際有限公司的大股東王爾奇已於2023年12月31日向美國證券交易委員會（SEC）提交了附表13G，表明該公司擁有大量所有權。根據該文件，王共持有107,126,140股普通股，佔公司證券類別的68.43％，此前調整了2024年2月8日生效的20比1遠期股票拆分。這種所有權包括通過Jolly Harmony Enterprises Limited和Er Pu International Limited直接持有的股份，這兩個實體均根據英屬維爾京群島法律組建由王全資擁有的Jolly Harmony Enterprises Limited持有95,381,140股股份，佔該類別的60.93％；而王擁有67％所有權的二浦國際有限公司持有11,745,000股股份，佔該類別的7.50％。該文件於2024年2月14日完成，聲稱這些股份是在正常業務過程中收購的，其目的不是爲了改變或影響Jin Medical International Ltd的控制權。
金醫療國際有限公司的大股東王爾奇已於2023年12月31日向美國證券交易委員會（SEC）提交了附表13G，表明該公司擁有大量所有權。根據該文件，王共持有107,126,140股普通股，佔公司證券類別的68.43％，此前調整了2024年2月8日生效的20比1遠期股票拆分。這種所有權包括通過Jolly Harmony Enterprises Limited和Er Pu International Limited直接持有的股份，這兩個實體均根據英屬維爾京群島法律組建由王全資擁有的Jolly Harmony Enterprises Limited持有95,381,140股股份，佔該類別的60.93％；而王擁有67％所有權的二浦國際有限公司持有11,745,000股股份，佔該類別的7.50％。該文件於2024年2月14日完成，聲稱這些股份是在正常業務過程中收購的，其目的不是爲了改變或影響Jin Medical International Ltd的控制權。
有用
沒用
